Literature DB >> 19931892

The unintended burden of increased prostate cancer detection associated with prostate cancer screening and diagnosis.

Peter C Albertsen1.   

Abstract

The increasing incidence of prostate cancer is associated with the intensity of screening for prostate-specific antigen. Although some men may benefit from the early detection of prostate cancer through screening, all men diagnosed with prostate cancer experience an effect on their mental and physical well-being and that of their families. In light of the recent publication of the United States Preventive Services Task Force recommendations concerning prostate-specific antigen testing, this article reviews the quality-of-life implications of prostate cancer screening and diagnosis, and explores risk reduction in screened men as a potential strategy to manage these issues. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19931892     DOI: 10.1016/j.urology.2009.08.078

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  12 in total

1.  Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

Authors:  Jonas Hugosson; Sigrid Carlsson; Gunnar Aus; Svante Bergdahl; Ali Khatami; Pär Lodding; Carl-Gustaf Pihl; Johan Stranne; Erik Holmberg; Hans Lilja
Journal:  Lancet Oncol       Date:  2010-07-02       Impact factor: 41.316

2.  Factors influencing Nigerian men's decision to undergo prostate specific antigen testing.

Authors:  Oghenetejiri Ubrurhe Enaworu; Ranjit Khutan
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

Review 3.  Randomized controlled screening trials for prostate cancer using prostate-specific antigen: a tale of contrasts.

Authors:  Kyle O Rove; E David Crawford
Journal:  World J Urol       Date:  2011-11-25       Impact factor: 4.226

4.  Treatment modalities for Māori and New Zealand European men with localised prostate cancer.

Authors:  Zuzana Obertová; Ross Lawrenson; Nina Scott; Michael Holmes; Charis Brown; Chunhuan Lao; Leanne Tyrie; Peter Gilling
Journal:  Int J Clin Oncol       Date:  2015-01-06       Impact factor: 3.402

Review 5.  Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.

Authors:  G Pron
Journal:  Ont Health Technol Assess Ser       Date:  2015-05-01

6.  A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.

Authors:  Murray D Krahn; Karen E Bremner; Shabbir M H Alibhai; Andy Ni; George Tomlinson; Audrey Laporte; Gary Naglie
Journal:  Qual Life Res       Date:  2013-04-06       Impact factor: 4.147

7.  Cell surface glycoproteomic analysis of prostate cancer-derived PC-3 cells.

Authors:  Sarah C Hubbard; Michael Boyce; Cheryl T McVaugh; Donna M Peehl; Carolyn R Bertozzi
Journal:  Bioorg Med Chem Lett       Date:  2011-05-18       Impact factor: 2.823

8.  Randomised prostate cancer screening trial: 20 year follow-up.

Authors:  Gabriel Sandblom; Eberhard Varenhorst; Johan Rosell; Owe Löfman; Per Carlsson
Journal:  BMJ       Date:  2011-03-31

9.  Quantitative metric profiles capture three-dimensional temporospatial architecture to discriminate cellular functional states.

Authors:  Lindsey McKeen-Polizzotti; Kira M Henderson; Basak Oztan; C Cagatay Bilgin; Bülent Yener; George E Plopper
Journal:  BMC Med Imaging       Date:  2011-05-20       Impact factor: 1.930

10.  The role of transrectal ultrasound in the diagnosis of prostate cancer: new contributions.

Authors:  Pedro Marinho Lopes; Luís Sepúlveda; Rui Ramos; Pedro Sousa
Journal:  Radiol Bras       Date:  2015 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.